1Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduoden-Ectomies in the 1990s. Ann Surg, 1997, 266: 248-260.
2Joukov V, Kalkkinen N, Alitalo K, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fit4 (VEGFR-3) and KDR(VEGFR-2) receptor tyrosine kinases. EMBO J, 1996, 15: 290-298.
3Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147: 9-19.
4Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angioganesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2002,62:157-166.
5He Y, Rajantie I, Hmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis [J].Cancer Res, 2004,64 (6): 3737-3740.
6Mario FM, Eva GM, Esther MV, et al. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity [J]. Cancer, 2004, 100(3):553 -560.
7Karkkainen MJ, Makinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research [J]. Nat Cell Biol, 2002,4( 1 ): E2-E5.
8Folkman J, Klagsbrun M. Angiogenesis factors [J]. Sceince,1987,235 (4787): 442-447.
9Holesh J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumor mediated by angiopoietin and VEGF [J]. Sceince, 1999,284(5422):1994-1998.
10Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features [J].Am J Pathol, 1999,155(6): 1967-1976.
